Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report. // Academic Pediatrics. – URL: https://www.sciencedirect.com/science/article/pii/S3050915725001973?dgcid=rss_sd_all
Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report. Academic Pediatrics. https://www.sciencedirect.com/science/article/pii/S3050915725001973?dgcid=rss_sd_all
“Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report.” Academic Pediatrics.
@article{article2398,
title = {Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report},
journal = {Academic Pediatrics},
url = {https://www.sciencedirect.com/science/article/pii/S3050915725001973?dgcid=rss_sd_all}
}
Publication date: Available online 14 November 2026 Source: AACE Endocrinology and Diabetes Author(s): Laura Pierotti, Chiara Sardella, Simone Della Valentina, Anna Dal Lago, Giacomo De Leo, Filomena Cetani